Allergan Holders Can Proceed With Botox Suit, Judge Rules

Allergan Inc. investors can seek to hold directors responsible for criminal sanctions and a $600 million penalty that the maker of the wrinkle smoother Botox was ordered to pay for marketing the drug for unapproved uses, a judge ruled.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.